Michael James Morrissey - Net Worth and Insider Trading

Michael James Morrissey Net Worth

The estimated net worth of Michael James Morrissey is at least $3 Million dollars as of 2023-05-31. Michael James Morrissey is the EVP, Head of Tech. Operations of Incyte Corp and owns about 45,452 shares of Incyte Corp (INCY) stock worth over $3 Million. Details can be seen in Michael James Morrissey's Latest Holdings Summary section.

Transaction Summary of Michael James Morrissey


Michael James Morrissey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael James Morrissey owns 1 companies in total, including Incyte Corp (INCY) .

Click here to see the complete history of Michael James Morrissey’s form 4 insider trades.

Insider Ownership Summary of Michael James Morrissey

Ticker Comapny Transaction Date Type of Owner
INCY Incyte Corp 2019-06-19 EVP & Head of Tech. Operations

Michael James Morrissey Latest Holdings Summary

Michael James Morrissey currently owns a total of 1 stock. Michael James Morrissey owns 45,452 shares of Incyte Corp (INCY) as of March 29, 2021, with a value of $3 Million.

Latest Holdings of Michael James Morrissey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INCY Incyte Corp 2021-03-29 45,452 61.55 2,797,571

Holding Weightings of Michael James Morrissey

Michael James Morrissey Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael James Morrissey has made a total of 1 transactions in Incyte Corp (INCY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Incyte Corp is the sale of 20,000 shares on March 29, 2021, which brought Michael James Morrissey around $2 Million.

Insider Trading History of Michael James Morrissey

Insider Trading Shares
Shares Change
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
Incyte Corp
Total 1
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael James Morrissey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael James Morrissey Ownership Network

Ownership Network List of Michael James Morrissey

No Data

Ownership Network Relation of Michael James Morrissey

Michael James Morrissey Owned Company Details

What does Incyte Corp do?

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Who are the key executives at Incyte Corp?

Michael James Morrissey is the EVP & Head of Tech. Operations of Incyte Corp. Other key executives at Incyte Corp include Principal Accounting Officer Thomas Tray , EVP & General Manager & Europe Jonathan Elliott Dickinson , and EVP & Chief Financial Officer Christiana Stamoulis .

Incyte Corp (INCY) Insider Trades Summary

Over the past 18 months, Michael James Morrissey made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net purchase of 2,510,403 shares made by Baker Bros. Advisors Lp , a net sale of 30,111 shares made by Vijay K Iyengar , and a net sale of 46,866 shares made by Barry P Flannelly .

In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 208,851 shares of Incyte Corp (INCY) were sold and 2,510,403 shares were bought by its insiders, resulting in a net purchase of 2,301,552 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.


Incyte Corp Insider Transactions

No Available Data

Michael James Morrissey Mailing Address

Above is the net worth, insider trading, and ownership report for Michael James Morrissey. You might contact Michael James Morrissey via mailing address: In Care Of Incyte Corporation, 1801 Augustine Cut Off, Wilmington De 19803.